"1052-9276"[Journal] - Search Results

Year	Number of Results
1996	23
1997	26
1998	23
1999	28
2000	37
2001	36
2002	34
2003	35
2004	32
2005	29
2006	31
2007	29
2008	33
2009	30
2010	34
2011	45
2012	44
2013	40
2014	40
2015	49
2016	44
2017	44
2018	64
2019	72
2020	117
2021	160
2022	154
2023	113
2024	104
2025	72
2026	95

1

Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.

Wolf J, Kist LF, Pereira SB, Quessada MA, Petek H, Pille A, Maccari JG, Mutlaq MP, Nasi LA. Wolf J, et al. Rev Med Virol. 2024 May;34(3):e2537. doi: 10.1002/rmv.2537. Rev Med Virol. 2024. PMID: 38666757 Review.

2

Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials.

Beladiya J, Kumar A, Vasava Y, Parmar K, Patel D, Patel S, Dholakia S, Sheth D, Boddu SHS, Patel C. Beladiya J, et al. Rev Med Virol. 2024 Jan;34(1):e2507. doi: 10.1002/rmv.2507. Rev Med Virol. 2024. PMID: 38282394

3

Influenza vaccines: Past, present, and future.

Kim YH, Hong KJ, Kim H, Nam JH. Kim YH, et al. Rev Med Virol. 2022 Jan;32(1):e2243. doi: 10.1002/rmv.2243. Epub 2021 May 4. Rev Med Virol. 2022. PMID: 33949021 Free PMC article. Review.

4

The concept of one health applied to the problem of zoonotic diseases.

Shaheen MNF. Shaheen MNF. Rev Med Virol. 2022 Jul;32(4):e2326. doi: 10.1002/rmv.2326. Epub 2022 Jan 20. Rev Med Virol. 2022. PMID: 35060214 Review.

5

An overview on the seven pathogenic human coronaviruses.

Kesheh MM, Hosseini P, Soltani S, Zandi M. Kesheh MM, et al. Rev Med Virol. 2022 Mar;32(2):e2282. doi: 10.1002/rmv.2282. Epub 2021 Aug 2. Rev Med Virol. 2022. PMID: 34339073 Review.

6

Covid-19 vaccines and variants of concern: A review.

Hadj Hassine I. Hadj Hassine I. Rev Med Virol. 2022 Jul;32(4):e2313. doi: 10.1002/rmv.2313. Epub 2021 Nov 9. Rev Med Virol. 2022. PMID: 34755408 Free PMC article. Review.

7

Tick-borne encephalitis: A comprehensive review of the epidemiology, virology, and clinical picture.

Chiffi G, Grandgirard D, Leib SL, Chrdle A, Růžek D. Chiffi G, et al. Rev Med Virol. 2023 Sep;33(5):e2470. doi: 10.1002/rmv.2470. Epub 2023 Jul 1. Rev Med Virol. 2023. PMID: 37392370 Review.

8

Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.

Hakami MA, Khan FR, Abdulaziz O, Alshaghdali K, Hazazi A, Aleissi AF, Abalkhail A, Alotaibi BS, Alhazmi AYM, Kukreti N, Binshaya AS. Hakami MA, et al. Rev Med Virol. 2024 Jul;34(4):e2554. doi: 10.1002/rmv.2554. Rev Med Virol. 2024. PMID: 38862398 Review.

9

Enterovirus Antibodies: Friends and Foes.

Mbani CJ, Morvan C, Nekoua MP, Debuysschere C, Alidjinou EK, Moukassa D, Hober D. Mbani CJ, et al. Rev Med Virol. 2024 Nov;34(6):e70004. doi: 10.1002/rmv.70004. Rev Med Virol. 2024. PMID: 39505825 Review.

10

Systematic Review of the Efficacy and Safety of RSV-Specific Monoclonal Antibodies and Antivirals in Development.

Sevendal ATK, Hurley S, Bartlett AW, Rawlinson W, Walker GJ. Sevendal ATK, et al. Rev Med Virol. 2024 Sep;34(5):e2576. doi: 10.1002/rmv.2576. Rev Med Virol. 2024. PMID: 39209729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,440 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,440 results

Results by year